Contact Us 

contactus@carepathrxllc.com
Category

News

Home / News

ExactCare Med Management Reduces Cost by 5 Percent for Patients with Complex Medical Needs

March 4, 2021 – ExactCare, a leading national medication management and pharmacy care provider and a CarepathRx company, today announced its comprehensive medication management solution has been proven to improve adherence, reduce health care utilization and generate total cost of care savings, according to a study conducted by RAND Corporation and recently published by the Journal of Managed Care + Specialty Pharmacy (JMCP).

The study, which reviewed medical and prescription drug encounter data of Medicare Advantage beneficiaries from one of the largest private insurers in the United States, examined the impact of ExactCare’s high-touch, multi-intervention approach for patients with complex medical needs. The study demonstrated the following:

  • Improved Medication Adherence. Statistically significant increases in adherence to statins and antihypertensive drugs
  • Decreases in Number and Length of Facility Admissions. Statistically significant decreases in skilled nursing facility (SNF) admission rates, SNF days, and inpatient days
  • Reductions in Total Cost of Care. Approximately $2,400 less in total cost of care per member per year, representing a 5 percent reduction in average costs

This study noted significant impact among patients with the most severe healthcare concerns.

“ExactCare’s unique approach to medication management was purposefully designed to serve people with chronic conditions,” said ExactCare President & CEO Dale Wollschleger, R.Ph. “For our patients, it is critical to provide a comprehensive approach that fully accounts for complex clinical issues as well as struggles with activities of daily living, as opposed to traditional pharmacy models that typically offer a single intervention focused on convenience. This study demonstrates that our robust services create better health outcomes for our patients and also address quality and cost objectives for healthcare organizations responsible for patient care.”

Read more at: www.exactcarepharmacy.com/blog-posts/exactcare-proven-to-reduce-total-cost-of-care-for-patients-with-complex-medical-needs.

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

About ExactCare
ExactCare, a CarepathRx company, provides solutions to overcome medication-related and chronic care challenges for patients with complex, chronic medical needs. Founded in 2009, the company drives better health for patients and better clinical, quality and economic outcomes for the healthcare organizations that care for them—including payors, health systems and hospitals, home health organizations, primary care practices and other providers. ExactCare provides comprehensive long-term pharmacy care to patients in assisted and independent living facilities, throughout transitions of care, and in their homes—with a focus on improving patient adherence to prescribed medications and enabling safer, more effective medication regimens. ExactCare also provides a number of additional value-based solutions, including HEDIS Gap Closure Assistance and Medication Therapy Management (MTM) Programs. ExactCare is licensed to serve patients nationwide. For more information, visit www.exactcare.com.

CarepathRx and Ephraim McDowell Regional Medical Center Announce Home Infusion Partnership

MERCER ISLAND, Wash., March 3, 2021CarepathRx, a leader in pharmacy and medication management solutions, announced today a new partnership with Ephraim McDowell Regional Medical Center to provide comprehensive home infusion services to their patients and communities in central Kentucky.

The result of this partnership allows Ephraim McDowell to expand their pharmacy capabilities and clinical oversight to improve patient care. “We are excited to partner with Ephraim McDowell,” said Keith Crawford, Chief Strategy Officer at CarepathRx. “Home infusion is a growing aspect in the healthcare delivery system and hospitals play an important role. Most conditions that require infusion therapies are diagnosed in a hospital setting or affiliated physician office. CarepathRx works directly with hospitals to build operational capabilities, achieve appropriate compliance, and accreditation, while providing full-service back-office and revenue cycle management.”

Ephraim McDowell Health is an integrated healthcare provider serving more than 119,000 residents from six counties in Kentucky. At the core of the system is Ephraim McDowell Regional Medical Center, a non-profit, 222-bed licensed hospital in Danville, Ky.

“Ephraim McDowell Health provides a comprehensive, integrated healthcare delivery system, which now includes an exceptional home infusion pharmacy program to meet the growing needs of our patient population,” said Joan Haltom, PharmD, FKSHP, System Director of Pharmacy, Ephraim McDowell Health. “CarepathRx was an indispensable partner throughout the development and implementation of our home infusion pharmacy, and we are excited to welcome our first patients.”

“This is an exciting partnership, and we are happy to be working with Ephraim McDowell,” said Mark Mikhael, Chief Pharmacy Officer at CarepathRx Infusion Solutions. “By managing the home infusion, the patient benefits from improved continuity of care from a provider they know and trust.”

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

Physicians Rank BioPlus #1 in Oncology for Independent Specialty Pharmacy Care

February 22, 2021 – A recent survey of staff at specialist offices conducted by Zitter Insights, a division of MMIT, awarded the top satisfaction score from office staff when it comes to oncology care from independent specialty pharmacies to BioPlus Specialty Pharmacy, part of CarepathRx. In addition to having the highest score in oncology, BioPlus also ranked #4 overall across all disease states in terms of office staff satisfaction with independent specialty pharmacies.

BioPlus scored the highest of the surveyed independent specialty pharmacies in Zitter Insights’ Specialty Pharmacy Office Staff Satisfaction Survey (Second half, 2020) when it comes to satisfaction in oncology care. This report, released early in 2021, measures satisfaction using Net Promoter Score™ (NPS). NPS is a well-established methodology to measure customer satisfaction and is used in this survey to determine how likely a physician’s office is to recommend a particular specialty pharmacy.

“We focus relentlessly on delivering a fast and easy patient and provider experience. And, we believe that a fundamental measure of our success is our company’s NPS score and the third-party reviews conducted by Zitter,” explains Stephen Vogt, Pharm.D., CEO of BioPlus. “Our strong market leadership position is a direct result of our team’s commitment to go beyond the expected. We have invested and will continue to invest aggressively in our fast and easy brand promise as we achieve tremendous growth,” Dr. Vogt adds.

Zitter Insights’ Specialty Pharmacy Office Staff Satisfaction Survey covers the time period of the second half of 2020 and surveyed more than 1,500 office staff in over ten therapeutic areas and covered a cross-section of the specialty pharmacy marketplace including the top 10 specialty pharmacies.

About BioPlus Specialty Pharmacy
Meet the first and only independent, national specialty pharmacy to back up ‘fast and easy’ with the Power of 2: BioPlus Specialty Pharmacy. Physician offices know in less than two hours whether a referred patient is accepted for treatment with the company’s 2-Hour Patient Acceptance Guarantee™. Prescriptions then move fast through the 2 Day Ready 2 Ship™ process. For qualifying prescriptions, medication refills are an easy 2 clicks away.

Read More

CarepathRx Launches Health System Solutions Business

MERCER ISLAND, Wash., December 28, 2020 – CarepathRx, a leader in pharmacy and medication management solutions, announced today the formation of CarepathRx Health System Solutions to specifically partner with hospitals and health systems to fully integrate their pharmacy operations, expand healthcare services, improve patient outcomes, and generate new revenue streams.

CarepathRx COO Randy Hyun will lead the Health System Solutions business as CEO, while maintaining his responsibilities with CarepathRx.

CarepathRx transforms health system pharmacies from a cost center into an active revenue generator through a powerful combination of technology, market-leading pharmacy solutions, and wrap-around patient services to include transition of care management, hospital home infusion, specialty pharmacy services, 340B optimization, and telepharmacy assistance. Over 600 hospitals use CarepathRx services that yield over 20M patient-related interactions annually.

“Pharmacy is the only therapy modality that transitions across all treatment domains and has the greatest impact on quality of care, clinical outcomes, and cost control,” said Randy Hyun, CEO of CarepathRx Health System Solutions. “We have all the assets, processes, and programs in place to seamlessly and efficiently implement a truly end-to-end pharmacy solution for our health system partners.”

“The concept of health-system pharmacies operating in multiple domains across healthcare is nothing new – yet it remains elusive. With payment models focusing on value and the quality of care, health systems need to view their pharmacy services as a value adding asset by servicing and monitoring patients across their healthcare journey”, concluded Hyun.

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

Contact: Keith Crawford/CarepathRx
Mobile: 720 854 5588
E-mail: keith.crawford@carepathrxllc.com

Industry Insight: CarepathRx CEO joins panel discussion on pharmacy channel trends

MERCER ISLAND, Wash., December 22, 2020 – John Figueroa, CarepathRx Chairman and Chief Executive Officer, will participate as a member of an esteemed panel of pharmacy experts to discuss pharmacy channel trends and opportunities during a web-based event hosted by Cantor Fitzgerald. The event will take place 4-5 p.m. Eastern Time Tuesday, Jan. 12, 2021.

Mr. Figueroa will lend his 30+ years of industry experience to discuss topics that include market share shifts in the pharmacy channel, value creation strategies, the regulatory environment, and 2021 trends.

To register for this event, please click here.

CarepathRx Facilitates COVID Patients to be Treated in the Home with Monoclonal Antibodies

MERCER ISLAND, Wash., December 7, 2020 – CarepathRx, a leader in comprehensive pharmacy and medication management solutions for health systems, announced it has helped facilitate the administration of bamlanivimab to a COVID patient in collaboration with one of its Texas Health System partners.

Bamlanivimab is an investigational medicine, developed by Eli Lilly, used for the treatment of COVID-19 in non-hospitalized adults and adolescents 12 years of age or older with mild to moderate symptoms and are at high risk for developing severe COVID-19 symptoms or the need for hospitalization. Bamlanivimab has not been approved but has been authorized for emergency use by FDA.

CarepathRx partners with leading health systems to expand their pharmacy operations to provide fully integrated infusion services and therapies in the home. “As the demand for hospital beds rises with an increase in COVID patients, managing hospital capacity by optimizing patient flow, such as transitioning infusion patients to the home for treatment, becomes critical”, said Keith Crawford, Chief Commercial Officer for CarepathRx. “By having the capabilities to effectively and seamlessly move patients into the home for infusion treatment can have a positive impact on hospital bed capacity”.

According to the FDA, Bamlanivimab has been shown in clinical trials to reduce coronavirus-related hospitalizations. “The drug is designed for those who have contracted the virus and are at a higher risk for developing more severe symptoms, Bamlanivimab is only authorized for patients who meet specific criteria”, said Mark Mikhael, Pharm D, Chief Pharmacy Officer at ProHealth Medical. “Being able to offer this treatment in a patient’s home may improve access due to increase patient comfort.”

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

About ProHealth Medical
ProHealth Medical is owned by CarepathRx and has been helping hospitals improve their financial performance and patient outcomes by establishing home infusion capabilities. By taking a systematic approach, ProHealth has been able to help health systems improve patient access to care and establish a sustainable outpatient infusion book of business that drives hospital brand recognition and increases hospital financial performance. For more information about ProHealth, visit www.prohealthmedical.com.

Contact: Keith Crawford/CarepathRx
Mobile: 720 854 5588
E-mail: keith.crawford@carepathrxllc.com

CarepathRx and UPMC Announce Landmark Partnership to Expand Pharmacy Solutions

MERCER ISLAND, Wash., and PITTSBURGH, December 1, 2020 CarepathRx, a leader in pharmacy and medication management solutions for vulnerable and chronically ill patients, announced today a partnership with UPMC’s Chartwell subsidiary that will expand patient access to innovative specialty pharmacy and home infusion services. Under the landmark agreement, CarepathRx will acquire the management services organization responsible for the operational and strategic management of Chartwell while UPMC becomes a strategic investor in CarepathRx. 

Founded in 2019 by seasoned health care executive John Figueroa and middle market private equity firm Nautic Partners LLC, CarepathRx has rapidly become a leader in delivering comprehensive pharmacy solutions to patients undergoing complicated medication therapies. By focusing on the most vulnerable patients, CarepathRx is seeking to break down the barriers of typical pharmacy care and medication management. Its suite of solutions caters to patients undergoing specialty and infusion therapies, often for a variety of chronic conditions. CarepathRx works closely with partners across the health care spectrum—including health systems, community physicians, home health agencies and payors. Today, CarepathRx delivers its services to more than 600 hospitals across the country.

This new partnership expands CarepathRx’s specialty and home infusion capabilities. “Our partnership with UPMC and Chartwell is an important step for CarepathRx. We set out to create a new approach to pharmacy care in the market—one that is centered on the patient and that works collaboratively with both the provider and the payor of health care,” said Figueroa, chief executive officer of CarepathRx. “We welcome the team at Chartwell to the CarepathRx family and are thrilled to partner with UPMC to help us achieve our mission.”

Health systems across the country continue to actively create capabilities to deliver a coordinated and consumer-friendly health care experience for patients. “Health systems with integrated pharmacy capabilities put themselves in a position to expand access to health care services, improve clinical and patient outcomes and generate new revenue streams—all through enhanced pharmacy operations,” said Randy Hyun, chief operating officer of CarepathRx. “We are committed to helping health systems transform their pharmacy operations by becoming an integral component of managing their patients’ health care relationships.”

As one of the most progressive, integrated health systems in the country, UPMC continues to invent and invest in new models of care delivery. “Health systems nationwide are looking for new ways of delivering care beyond the walls of the hospital to drive better clinical outcomes at lower costs,” said Leslie Davis, senior vice president of UPMC and executive vice president and chief operating officer of the Health Services Division. “Chartwell’s agreement with CarepathRx will allow other health systems  to benefit from the pharmacy model that UPMC has created, while delivering even better care and service for our patients and Health Plan members.” 

The transaction is expected to close within 30 days, and terms were not disclosed. Cantor Fitzgerald & Co. served as financial advisor to Chartwell in the formation of the management services organization and partnership with CarepathRx. 

#  #  #

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

About Chartwell Pennsylvania, LP
Chartwell Pennsylvania, LP, is one of the largest and most clinically advanced providers of home infusion, specialty pharmacy, and enteral nutrition in the nation. Chartwell is a limited partnership among UPMC, Butler Health System, Heritage Valley Health System, and Washington Health System with three branch locations in Altoona, Erie, and Pittsburgh. For more than 30 years, Chartwell has provided the latest in advanced therapies and medications to patients for the treatment of chronic, rare, and/or complex conditions. The pharmacy provides services, therapies, and medications for home infusion, specialty pharmacy, and enteral nutrition throughout Pennsylvania, West Virginia, Ohio, New York, Florida, and South Carolina. www.chartwellpa.com.

About UPMC
A $21 billion health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. The largest nongovernmental employer in Pennsylvania, UPMC integrates more than 90,000 employees, 40 hospitals, 700 doctors’ offices and outpatient sites, and a 3.8 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. In the most recent fiscal year, UPMC contributed $1.4 billion in benefits to its communities, including more care to the region’s most vulnerable citizens than any other health care institution, and paid more than $500 million in federal, state and local taxes. Working in close collaboration with the University of Pittsburgh Schools of the Health Sciences, UPMC shares its clinical, managerial, and technological skills worldwide through its innovation and commercialization arm, UPMC Enterprises, and through UPMC International. U.S. News & World Report consistently ranks UPMC Presbyterian Shadyside among the nation’s best hospitals in many specialties and ranks UPMC Children’s Hospital of Pittsburgh on its Honor Roll of America’s Best Children’s Hospitals. www.UPMC.com.

About Nautic
Nautic Partners, LLC is a middle-market private equity firm that focuses on three industries: healthcare, industrials, and services. Nautic has completed 140 platform transactions throughout its 34-plus year history. Nautic’s strategy is to partner with management teams to accelerate the growth trajectory of its portfolio companies via add-on acquisitions, targeted operating initiatives, and increased management team depth. Nautic generally makes equity investments of $25 to $250 million or more. For more information, please visit www.nautic.com.

www.upmc.com/media

Contact: Keith Crawford/CarepathRx
Mobile: 720 854 5588
E-mail: keith.crawford@carepathrxllc.com

Contact: Wendy Zellner/UPMC
Office: 412 586 9777
Mobile: 412 973 7266
Email: ZellnerWL@upmc.edu

John Figueroa Named Outstanding Alumni in Healthcare

MERCER ISLAND, Wash., November 10, 2020 – Pepperdine University has named CarepathRx Founder and CEO John Figueroa a 2020 Outstanding Alumni in Healthcare Honoree. This award honors alumni in healthcare that have made significant contributions to the industry, exemplified leadership within the healthcare profession, and are redefining how healthcare will have an impact for years to come.

“Being recognized as an Outstanding Alumni at Pepperdine is truly an honor, both personally and professionally,” Mr. Figueroa said in an interview with Pepperdine. “I have dedicated my career to changing the healthcare landscape for the better and am thrilled to be recognized for the work that I have been associated with and the amazing people with whom I have teamed over the years.”

“Serving in healthcare in the year of the COVID-19 pandemic forced us to do some very unique things,” he continued. “We focused our company to enhance our services to deliver critically needed medications to people outside of normal healthcare locations. We modified our technology, resources, and people to connect with patients directly and to provide healthcare services at their home or through telemedicine/telepharmacy. This honor really is recognition for the amazing job my team performed in this time of crisis.”

To read more from Mr. Figueroa’s interview, visit the Pepperdine University website.

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide.

1 2
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound